TABLE 3.
Name | Gene/inheritance | Seizures | Commonly associated signs | Onset age | Progression |
---|---|---|---|---|---|
Lafora; EPM2 (EPM2A& NHLRC1) |
6p22.3 6p24.3 AR |
Generalized tonic–clonic, myoclonic, and visual (frequent) | Frequently severe dementia | Late childhood, adolescence | Fast (less severe in some cases) |
Unverricht‐ Lundborg: EPM1 (CSTB) |
21q22.3 AR |
Myoclonic, tonic–clonic (rare, often responsive to treatment) | Ataxia (variable but not severe cognitive decay) | Late childhood, adolescence | Slow, often stabilization |
Sialidoses, I (NEU1) |
6p21.33 AR |
Myoclonic, tonic–clonic (rare) | Cherry red spots, visual loss (can be lacking), urinary sialyloligosaccharides | Second to third decades of life | Slow |
Sialidoses, II (NEU1) |
6p21.33 AR |
Myoclonic, tonic–clonic | Dysmorphisms, hepatosplenomegaly, early cognitive impairment, ataxia | Early childhood (rarely later) | Variable, often fast |
NCL AR (KCTD7) |
7q11.21 AR |
Myoclonic, tonic–clonic | Mental retardation, dysarthria, ataxia | Early childhood | Variable |
NCL AR (CLN6) |
15q23 AR |
Myoclonic, tonic–clonic | Cognitive deterioration, extrapyramidal, ataxia | Adults | Intermediate |
EPM1B PRICKLE1 |
12q12 AR |
Myoclonic, tonic–clonic | Ataxia, mild mental retardation | Late childhood–adolescence | Slow |
EPM4 SCARB2 |
4q21.1 AR |
Rare (or absent) tonic–clonic | Ataxia; with or without renal failure | Adolescence‐juvenile | Fast (death at around 30 years) |
EPM6 GOSR2 |
17q21.32 AR |
Absence, or tonic–clonic (not predominant) | Ataxia, preceding myoclonus, neuropathy dementia | Early childhood | Variable |
EPM7 MEAK KCNC1 |
11p15.1 AD |
Tonic–clonic Severe myoclonus |
Ataxia, mild cognitive impairment | Childhood to adolescence | Fast (wheel‐chair bound since late teen‐age) |
EPM8 CERS1 |
19p13.11 AR |
Tonic–clonic | Ataxia, other movement disorders, dementia | Early childhood | Variable (few affected) |
EPM9 LMNB2 |
19p13.3 AR |
Tonic–clonic | Cognitive delay, scoliosis, muscle atrophy | Childhood | Variable (few affected) |
EPM10 PRDM8 |
4q21.21 AR |
Undefined | Ataxia, spasticity, and cognitive decay | Childhood | Variable (few affected) |
EPM11 SEMA6B |
19p13.3 AR |
Various types | Developmental regression | Childhood | Variable (few affected) |
EPM12 SLC7A6OS |
16q22.1 AR |
Tonic–clonic | Ataxia, mild cognitive impairment | Juvenile | Slow (few affected) |
MERRF MERRF/MELAS overlap |
Various mitochondrial genes Mutations at nucleotide 8344 in most Maternal |
Mostly Tonic–clonic | Ataxia, migraine, hearing loss, (short stature, pes cavus, ophthalmoparesis, myopathy) | Adolescent‐adult | Variable |
FAME BAFME |
Intronic TTTCA and TTTTA repeat in different loci AD |
Rare (or absent) tonic–clonic | Late mild cognitive deficits or psychiatric symptoms | Adult (juvenile) | Very slow |
Abbreviations: AD, autosomal dominant; AR, autosomal recessive; BAFME, Benign adult familial myoclonic epilepsy; FAME, adult familial myoclonic epilepsy; MEAK, Myoclonic epilepsy and ataxia due to KCNC1 mutation; NCL, neuronal Ceroid Lipofuscinoses.